| GO | Name |
| GO:0000209 | protein polyubiquitination |
| GO:0001782 | B cell homeostasis |
| GO:0001783 | B cell apoptotic process |
| GO:0002230 | positive regulation of defense response to virus by host |
| GO:0002269 | leukocyte activation involved in inflammatory response |
| GO:0002334 | transitional two stage B cell differentiation |
| GO:0002344 | B cell affinity maturation |
| GO:0002447 | eosinophil mediated immunity |
| GO:0005102 | signaling receptor binding |
| GO:0006954 | inflammatory response |
| GO:0006955 | immune response |
| GO:0006959 | humoral immune response |
| GO:0010467 | gene expression |
| GO:0019221 | cytokine-mediated signaling pathway |
| GO:0019724 | B cell mediated immunity |
| GO:0023019 | signal transduction involved in regulation of gene expression |
| GO:0023035 | CD40 signaling pathway |
| GO:0033209 | tumor necrosis factor-mediated signaling pathway |
| GO:0034097 | response to cytokine |
| GO:0038173 | interleukin-17A-mediated signaling pathway |
| GO:0042110 | T cell activation |
| GO:0042119 | neutrophil activation |
| GO:0042493 | response to drug |
| GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0043588 | skin development |
| GO:0048255 | mRNA stabilization |
| GO:0061630 | ubiquitin protein ligase activity |
| GO:0070254 | mucus secretion |
| GO:0070534 | protein K63-linked ubiquitination |
| GO:0097400 | interleukin-17-mediated signaling pathway |
| GO:1990959 | eosinophil homeostasis |